NCT01712360View on ClinicalTrials.gov

Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis

PHASE4CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Tinea PedisTinea Cruris
Interventions
DRUG

NAFT500 (pediatric)

Applied to both feet and groin area

DRUG

NAFT600 (pediatric)

Applied to both feet only

DRUG

NAFT500 (adult)

Applied to both feet and groin area

DRUG

NAFT600 (adult)

Applied to both feet

Trial Locations (4)

77802

Merz Investigative Site #001261, College Station

78759

Merz Investigative Site #001272, Austin

Unknown

Merz Investigative Site #180001, Santo Domingo

Merz Investigative Site #504001, San Pedro Sula

All Listed Sponsors
lead

Merz North America, Inc.

INDUSTRY

NCT01712360 - Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis | Biotech Hunter | Biotech Hunter